Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Nevirapine placebo
DRUG
2 trials
Sponsors
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions
HIV Infections
Phase 3
Nevirapine (NVP) Use to Prevent Mother-to-Child Transmission of HIV
Completed
NCT00074399
National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections
Start: 2001-02-28
End: 2007-04-30
Updated: 2009-08-07
Using Nevirapine to Prevent Mother-to-Child HIV Transmission During Breastfeeding
Completed
NCT00074412
National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections
Start: 2007-01-31
End: 2011-11-30
Updated: 2023-02-16
Related Papers
Evaluation of adherence measures of antiretroviral prophylaxis in HIV exposed infants in the first 6 weeks of life.
2015-03-19
8 citations
Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial.
2011-12-22
94 citations
Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials.
2008-07-01
183 citations